Gout clinical trials
The registry lists 345 studies for Gout across more than 10 countries. 49 are recruiting or about to start. 268 of them are mainly about Gout (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its narrower condition Arthritis, Gouty too: 375 studies, 60 open.
Get an email when these change. Save the Gout studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Ardea Biosciences, Inc. (21) · Takeda (15) · LG Chem (10) · Assistance Publique - Hôpitaux de Paris (9) · Jiangsu HengRui Medicine Co., Ltd. (9) · Amgen (8) · Regeneron Pharmaceuticals (7) · Novartis Pharmaceuticals (7)
What is being tested here
Drugs under test in Gout studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare · Phase 3 · Olatec Therapeutics, Inc.
- Apr 2027Tigulixostat (IBI128) vs Febuxostat in Gout · Phase 3 · Innovent Biologics Technology Limited (Shanghai R&D Center)
- Nov 2027A Study of Dotinurad Versus Allopurinol in Participants With Gout · Phase 3 · Crystalys Therapeutics
- Nov 2026Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients · Arthrosi Therapeutics
- Dec 2026The Effects of a Probiotic Food Supplement in Hyperuricaemia · Örebro University, Sweden
- Dec 2026Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia · Shenyang Sunshine Pharmaceutical Co., LTD.
- Dec 2026A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout. · Shanghai Institute Of Biological Products
- Jan 2027Improving Gout Care After an ED Visit · University of Alabama at Birmingham
- Feb 2027the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More · Seoul National University Hospital
- Jun 2027HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness · Haiphong University of Medicine and Pharmacy
Who these studies take
Of the 30 Gout studies recruiting now, 14 (47%) set no upper age limit and 10 (33%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 26 (87%) | 26 (87%) |
| 30 | 29 (97%) | 29 (97%) |
| 40 | 30 (100%) | 30 (100%) |
| 50 | 30 (100%) | 30 (100%) |
| 65 | 29 (97%) | 29 (97%) |
| 75 | 23 (77%) | 23 (77%) |
| 85 | 17 (57%) | 17 (57%) |
Across all 345 studies, recruiting or not: 40% stop at 75 or younger and 20% at 65; 5% take children; <1% are for women only and 7% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Gout studies take
Of 40 phase 1 interventional studies under Gout, half reached primary completion within 6 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 6 mo1–14 · 40 studies | 6 mo1–14 · 37 studies | — |
| Phase 2 | 14 mo7–22 · 30 studies | 14 mo7–19 · 25 studies | — |
| Phase 3 | 20 mo17–25 · 21 studies | — | — |
| Phase 4 | 21 mo17–39 · 18 studies | — | — |
| Interventional, no phase | 29 mo11–43 · 35 studies | — | 29 mo11–43 · 34 studies |
| Observational | 67 mo20–122 · 20 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting1
- Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With GoutOct 21, 2026NCT06887452
Studies
Recruiting first, then most recently updated. Showing 50 of 345. Browse all 345 → or search them.
- Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in GoutRecruitingNCT04875702Phase 41 country
- A Study of Dotinurad Versus Allopurinol in Participants With GoutRecruitingNCT07089875Phase 33 countries
- The Remote Monitoring of Gout StudyEnrolling by invitationNCT06822933Not applicable1 country
- Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With GoutRecruitingNCT06887452Not applicable1 country
- A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled GoutRecruitingNCT07388498Phase 32 countries
- Metformin in Safety and Efficacy in Gouty PatientsRecruitingNCT06924658Phase 21 country
- A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)RecruitingNCT07280156Phase 23 countries
- A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout ParticipantsRecruitingNCT07535034Phase 21 country
- Evaluation of the Impact of Dietary Education and Intervention on Gout Patients Receiving Urate-Lowering TherapyEnrolling by invitationNCT07834840Not applicable1 country
- Mazdutide for Weight Management and Gout in Adults With ObesityNot yet recruitingNCT07824895Phase 4
- The Correlation Between Sodium Urate (MSU) Deposition and Coronary Atherosclerosis in Patients With Foot GoutNot yet recruitingNCT077840491 country
- SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) TrialRecruitingNCT06674109Phase 41 country
- A Study of IN026 in Participants With Refractory GoutRecruitingNCT07587684Phase 11 country
- The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution TimeNot yet recruitingNCT07661030Phase 4
- Musculoskeletal Ultrasound for Differentiating Rheumatoid and Gouty ArthritisNot yet recruitingNCT07657156
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral F-02-2-Na Tablets in Adult SubjectsEnrolling by invitationNCT07324434Phase 11 country
- 24-Week Recurrence Rate of Gout Following Firsekibart TreatmentNot yet recruitingNCT07625514Not applicable1 country
- Efficacy and Safety of Scheduled Versus As-Needed Firsekibart Administration for the Prevention of Gout Recurrence: A Multicenter, Open-Label, Randomized Controlled TrialNot yet recruitingNCT07616531Not applicable1 country
- Probiotic-Uricase Complex Preparation for Improving Uric Acid Metabolism in Patients With HyperuricemiaNot yet recruitingNCT07613164Not applicable
- The Remote Monitoring of Gout Feasibility Study in Primary CareRecruitingNCT07490522Not applicable1 country
- the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or MoreRecruitingNCT06622603Phase 41 country
- Dose Response of Exercise for Arthritis ManagementRecruitingNCT06880653Not applicable1 country
- The Orienting StudyRecruitingNCT075041461 country
- Clinical Trial of BR2251 Tablets for Patients With Primary Gout and HyperuricemiaNot yet recruitingNCT07498647Phase 2
- The Effects of a Probiotic Food Supplement in HyperuricaemiaRecruitingNCT07141888Not applicable1 country
- Study of Dapansutrile Tablets in Subjects With an Acute Gout FlareRecruitingNCT05658575Phase 2/35 countries
- Time Required to Dissolve Urate DepositsRecruitingNCT066690001 country
- HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-EffectivenessNot yet recruitingNCT07369622Phase 4
- Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout FlaresRecruitingNCT07346079Phase 41 country
- Improving Gout Care After an ED VisitRecruitingNCT06534554Not applicable1 country
- A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.RecruitingNCT06298071Phase 11 country
- Orlistat and Weight Management for Uric Acid Control in Obese Gout: A RCTNot yet recruitingNCT07326839Not applicable1 country
- Effect of Dotinurad in Hyperuricemia With HypertensionRecruitingNCT06834230Phase 41 country
- Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic HyperuricaemiaRecruitingNCT07002762Not applicable1 country
- Developing A Gout Action Plan in Primary Care Setting in SingaporeNot yet recruitingNCT07061587Not applicable1 country
- Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and HyperuricemiaRecruitingNCT06629376Phase 11 country
- Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release TabletsRecruitingNCT06966635Phase 41 country
- Maintenance or Withdrawal of Urate Lowering Therapy According to Ultrasound Features in Gout Patients: a Randomised Controlled Trial Stop Treatment In GoutNot yet recruitingNCT06956885Phase 2
- Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With GoutRecruitingNCT055465931 country
- Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic AdjustmentsRecruitingNCT059276881 country
- Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2RecruitingNCT066940121 country
- Study on the Efficacy and Safety of Thermotherapy in the Treatment of Refractory GoutNot yet recruitingNCT06653686Not applicable
- The Effects of Limb Elevation During Gout Flare EpisodesNot yet recruitingNCT06207045Not applicable1 country
- Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic DiseasesRecruitingNCT032142631 country
- A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute GoutNot yet recruitingNCT06169891Phase 3
- Probiotics for Gout / Hyperuricemia: A Randomized, Intervention, Parallel Controlled, Multicenter Clinical TrialRecruitingNCT04199325Not applicable1 country
- CRYSTALILLE Cohort: Getting the Whole Picture of Crystal-related ArthropathiesRecruitingNCT046950281 country
- Rasburicase Treatment in Chronic Gouty ArthritisRecruitingNCT05312268Phase 41 country
- Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)Not yet recruitingNCT054733251 country
- Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed AdministrationCompletedNCT05109936Phase 31 country